Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

With the drop in overdose deaths, “we're celebrating: a death toll that exceeds total American combat fatalities in Vietnam, ...

The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more transparency.

Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news ...

PeaceHealth's move to replace ER doctors with ApolloMD clinicians is testing a new state law limiting corporate medicine.

Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.

A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.

Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.

How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.

Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug Wegovy.

Universal Health Services, a behavioral health provider that operates over 340 inpatient facilities across 40 states, announced Monday that it will ...

There is growing concern that the FDA is shunning advisory committees that allow agency leaders, drugmakers, patients, and doctors to speak their minds in public ...